The majority of autologous cytolytic T-lymphocyte clones derived from peripheral blood lymphocytes of a melanoma patient recognize an antigenic peptide derived from gene Pmel17/gp100.
about
Specific increase in potency via structure-based design of a TCR.Identifying source proteins for MHC class I-presented peptides.The basis of T-cell-mediated immunity to chronic myelogenous leukemia.microRNA-155, induced by interleukin-1ß, represses the expression of microphthalmia-associated transcription factor (MITF-M) in melanoma cells.Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma.Presence of tumor-infiltrating lymphocytes and a dominant nodule within primary melanoma are prognostic factors for relapse-free survival of patients with thick (t4) primary melanoma: pathologic analysis of the e1690 and e1694 intergroup trialsUp-regulation of specific tyrosinase mRNAs in mouse melanomas with the c2j gene substituted for the wild-type tyrosinase allele: utilization in design of syngeneic immunotherapy models.Selective increase in specific alternative splice variants of tyrosinase in murine melanomas: a projected basis for immunotherapy.Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives.Inefficient exogenous loading of a tapasin-dependent peptide onto HLA-B*44:02 can be improved by acid treatment or fixation of target cells.Immunization with analog peptide in combination with CpG and montanide expands tumor antigen-specific CD8+ T cells in melanoma patients.Insights into the processing of MHC class I ligands gained from the study of human tumor epitopes.Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives.Human Tumor Antigens and Cancer Immunotherapy.Genes coding for melanoma antigens recognised by cytolytic T lymphocytes.T Cell Receptor Profiling in Type 1 Diabetes.Identification of a public CDR3 motif and a biased utilization of T-cell receptor V beta and J beta chains in HLA-A2/Melan-A-specific T-cell clonotypes of melanoma patients.
P2860
Q34383054-8A41D6A5-991A-4F68-8955-F7A7DA7C1DFAQ34553385-0BCC76B6-12DD-41F7-8401-EDD35BDB4100Q35022552-FE005D86-2E16-42ED-A1D8-98D5C0D000F8Q35597356-B3E85271-EC3F-4A64-859F-4C275EA365D3Q36403544-BD2787A4-1D41-4208-ADE5-0433C677120AQ36652356-272E44F9-18AF-4890-ADB5-5910B89A1C84Q36660661-80C39E49-ED26-45E6-BF5C-2501104711ADQ36772676-8F25F288-D9DC-49DB-9E4D-2E8BE5CBE548Q37118164-535181F0-D396-4523-A6EC-72E8B5555AC3Q37155831-58F5FC6D-4ED6-43B5-B4CE-2A02D446A1F0Q37513109-46AA7C63-112B-4901-B160-66139FE0060BQ37851050-0AB47041-61A1-4C97-8730-C53BF0D41167Q38047050-6F3B3FA1-1453-4E8F-B966-251137F7F6E9Q41533232-512A3666-EA8A-4A28-9DB6-9E34630E7FD1Q41625946-E87F52C1-DF7F-4B7A-A23A-3D2E47B64028Q42374922-99BE345B-1520-43D2-95B7-D70ED60C7BA0Q43147458-D95B12F5-B7E3-42C9-8EA1-9CE1C2C8D0D3
P2860
The majority of autologous cytolytic T-lymphocyte clones derived from peripheral blood lymphocytes of a melanoma patient recognize an antigenic peptide derived from gene Pmel17/gp100.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
The majority of autologous cyt ...... erived from gene Pmel17/gp100.
@en
type
label
The majority of autologous cyt ...... erived from gene Pmel17/gp100.
@en
prefLabel
The majority of autologous cyt ...... erived from gene Pmel17/gp100.
@en
P2093
P1476
The majority of autologous cyt ...... erived from gene Pmel17/gp100.
@en
P2093
Marchand M
Renauld JC
P2888
P356
10.1111/1523-1747.EP12298177
P407
P577
1996-07-01T00:00:00Z
P5875
P6179
1010959592